Nov 8 Indian drugmaker Cipla cut
prices of three cancer drugs between 50 percent and 64 percent
with immediate effect, after it announced similar price cuts for
three drugs early this year.
Lung cancer drug Erlocip would cost 9,900 rupees for 30
tablets instead of 27,000 rupees earlier, while breast cancer
treatment Docetax would be priced 1,650 rupees instead of 3,300
rupees, Cipla said in a statement on Thursday.
Cipla last month won a case against Roche Holding,
which accused the Indian company of infringing patent on cancer
drug Tarceva, which Cipla sells under the brand name Erlocip.
Capegard, another drug to treat metastatic colorectal and
colon caner, would be priced 600 rupees for 10 tablets instead
of 1,200 rupees, it said.
(Reporting by Kaustubh Kulkarni and Manoj Dharra in Mumbai;
Editing by Subhranshu Sahu)